MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Funding Programs
Pilot & Feasibility
Conference Support
Summer Student
Collaborative
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Tissues & Samples
Mouse Diet
Breeding Schemes
Validation Criteria
Histology
IMPC / KOMP Data
Publications
Bioinformatics
FUNDING PROGRAMS
Pilot & Feasibility
Conference Support
Summer Student
Collaborative
CONTACT
PARTICIPANT AREA
Login
Request Account
▹
DiaComp Funded Abstracts
Program Application Abstract
Glucocorticoids Induce Osteoporosis through Decreased Sensory Innervation
Parrott, Kendall
(Johns Hopkins University)
Mentor: Crane, Janet L. (Johns Hopkins University School of Medicine)
Summer Student Program
Glucocorticoid therapy is the most common cause of secondary osteoporosis in children and the leading iatrogenic cause of the disease. The risk of fracture escalates by as much as 75% within the first 3 months after the initiation of glucocorticoid therapy and fracture risk increases before changes in bone density are observed, suggesting other factors are involved. Sensory innervation of bone has recently been associated with neuronal regulation of bone mass. We hypothesized that glucocorticoids impair bone innervation by decreasing paracrine factors regulating sensory innervation. Using osteoclast cultured media in a microfluidic culture platform with dorsal root ganglion neurons, we found that osteoclasts secrete Netrin to stimulate sensory innervation. To test if glucocorticoids impair sensory innervation by decreasing osteoclast netrin secretion, we first examined wild type (WT) mice treated intraperitoneally with either Vehicle (1xPBS) or Prednisolone 10mg/m- daily from 2 to 6 weeks of age and compared the effects of glucocorticoids to Cathepsin K knockout (Ctsk-/-) mice, as Ctsk-/- have an osteoclast-rich form of osteopetrosis. Glucocorticoids decrease both osteoclast activity and sensory innervation in WT mice, as assessed by Tartrate-resistant acid phosphatase (Trap) and Calcitonin gene-related peptide (CGRP) staining, respectively. Trap/Netrin costaining was also reduced in glucocorticoid (6.083 ± 1.433; n=12) relative to vehicle treated WT mice (30.33 ± 2.273; n=9). Ctsk-/- mice treated with glucocorticoids had lower numbers of TRAP/Netrin 1 positive cells (12 ± 6.715; n=7) relative to the vehicle Ctsk-/- group (37.29 ± 11.75; n=12). Ctsk-/- mice treated with glucocorticoids also had a significantly lower percentage of CGRP (3.832 ± 0.7026; n=24) than the vehicle Ctsk-/- group (11.2 ± 2.558; n=18), but similar to WT groups (vehicle = 5.799 ± 0.8963; n=24; glucocorticoid = 2.571 ± 0.5528; n=24). Genetic loss of Cathepsin K therefore partially abrogated glucocorticoids reduction in sensory innervation. We also examined Trap-Cre::Netrinf/f (NetrinTrap-/-) and Netrinf/f (WT) mice using Microcomputer tomography to assess the role of Netrin in regulation of bone mass. Using MicroCT, we found that specific deletion of Netrin-1 in Trap expressing cells results in decreased bone mass. These data suggest that glucocorticoids cause a decrease in Netrin 1 to impair bone sensory innervation, which may contribute to decreased bone density and osteoporosis. These observations have implications for a possible treatment target to reduce glucocorticoid induced bone disease.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
Internet Explorer
Google Chrome
FireFox
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!